Marco Tagliamento

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Maria Giovanna Dal Bello, Rosangela Filiberti, Angela Alama et al. · Journal of Translational Medicine · 2019 · 203 citations · Full text

Medicine, Oncology, Pharmacology +17

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

David J. Pinato, Mark Bower, Lorenza Scotti et al. · The Lancet Oncology · 2021 · 136 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Radiomic Detection of EGFR Mutations in NSCLC

Giovanni Rossi, Emanuele Barabino, Alessandro Fedeli et al. · Cancer Research · 2020 · 111 citations · Full text

Medicine, Oncology, Radiology +17

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer

Selene Ottonello, Carlo Genova, Vincenzo Fontana et al. · Frontiers in Immunology · 2020 · 109 citations · Full text

Life Sciences, Immunology, Oncology +17

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

David J. Pinato, Daniela Ferrante, Georgina Hanbury et al. · The Lancet Oncology · 2022 · 80 citations · Full text

Medicine, Infectious Diseases, Oncology +16